Author Question: About what time in history was AIDS declared a serious health care problem in the U.S? a. ... (Read 81 times)

Hungry!

  • Hero Member
  • *****
  • Posts: 1,071
About what time in history was AIDS declared a serious health care problem in the U.S?
 
  a. early-1950s
  b. mid-1960s
  c. early-1970s
  d. early-1980s

Question 2

Which of the following is NOT a vulnerable population?
 
  a. Nonconformist groups.
  b. Racial groups.
  c. Dependent groups.
  d. Special interest groups.



xMRAZ

  • Sr. Member
  • ****
  • Posts: 363
Answer to Question 1

d

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

xMRAZ

  • Sr. Member
  • ****
  • Posts: 363

 

Did you know?

During the twentieth century, a variant of the metric system was used in Russia and France in which the base unit of mass was the tonne. Instead of kilograms, this system used millitonnes (mt).

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library